None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)age 20~75 2) pathologically confirmed rectal adenocarcinoma of which lower margin is located within 15cm from anal verge 3) radiologically confirmed non-metastatic rectal cancer (cTanyNantM0) 4) ECOG performance status 0-2 5) ASA = 3 6) A patient who understands this clinical trial and agrees to be enrolled
Exclusion criteria
Exclusion criteria: 1) anticipated other organ resection 2) metastatic disease 3) one who have been treated for infections or have taken antibiotics within 2 weeks before surgery 4) severe major organ dysfunction (heart, lung, liver, kidney) 5) A patient who is taking steroid or immunosuppresants 6) inflammatory bowel disease 7) A patient who has undergone chemotherapy within 1 month due to malignant disease of other organ 8) decrease in white blood cell for various reasons 9)pregnant or lactating women 10)local resection of rectal cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| surgical site infection rate during first 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| overall complication;adverse event;C. difficile colitis;incisional SSI;organ/space SSI;anastomotic leakage rate | — |
Countries
Korea, Republic of
Contacts
Korea University Ansan Hospital